Therefore, we will not be presenting this data at the GU Malignancy conference taking place in late November and will instead target a presentation sometime in 2025. The Phase 1b/2 clinical trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback